Matt Ports

Matt Ports has over two decades of experience in the pharmaceutical and biotechnology sectors, currently serving as an Executive Oncology Account Specialist at Ipsen since January 2017. Previously, Matt has held various positions in oncology and biopharmaceutical sales, including Senior Oncology Account Specialist and Oncology Account Specialist at Ipsen, as well as Sr. Biopharmaceutical Specialist at Amgen from August 2009 to December 2016. Earlier in the career, Matt worked as a Specialty Representative at Pfizer Pharmaceuticals from August 2000 to July 2009. Matt holds a degree in Health Care Business Management from Heidelberg University, earned between 1993 and 1996.